Article info

Download PDFPDF

Review
Biosimilars in rheumatology: what the clinician should know

Authors

  • Gilberto Castañeda-Hernández Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, Distrito Federal, MexicoCentro Latino Americano de Pesquisa em Biológicos, Rio de Janeiro, Brazil PubMed articlesGoogle scholar articles
  • Rodrigo González-Ramírez Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, Distrito Federal, Mexico PubMed articlesGoogle scholar articles
  • Jonathan Kay Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Morton A Scheinberg Hospital AACD, São Paulo, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gilberto Castañeda-Hernández; gcastane{at}cinvestav.mx
View Full Text

Citation

Castañeda-Hernández G, González-Ramírez R, Kay J, et al
Biosimilars in rheumatology: what the clinician should know

Publication history

  • Received November 28, 2014
  • Revision received April 20, 2015
  • Accepted April 21, 2015
  • First published May 23, 2015.
Online issue publication 
June 29, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.